This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02865/identifier/pdb/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02865/identifier/pubchem-compound/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02865/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02865/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02865
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n8:DB02865 n9:DB02865
dcterms:title
Glucosamine 4-Phosphate
adms:identifier
n4:46509132 n11:GP4 n12:448057 n13:DB02865
n5:IUPAC-Name
n6:271B601C-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6022-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6021-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B601E-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B601F-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6020-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B601A-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B601B-363D-11E5-9242-09173F13E4C5 n6:271B6018-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6019-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6028-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6029-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6023-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6024-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6026-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6025-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6027-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B602E-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B6030-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6031-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B602D-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B602C-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B602F-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B601D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B602A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B602B-363D-11E5-9242-09173F13E4C5